These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8285198)

  • 1. Influence of erythropoietin on dialyzer reuse, heparin need, and urea kinetics in maintenance hemodialysis patients.
    Veys N; Vanholder R; De Cuyper K; Ringoir S
    Am J Kidney Dis; 1994 Jan; 23(1):52-9. PubMed ID: 8285198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of erythropoietin treatment on dialyzer reuse.
    Kes P; Reiner Z; Starcević B; Ratković-Gusić I
    Blood Purif; 1997; 15(2):77-83. PubMed ID: 9087814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
    Ouseph R; Brier ME; Ward RA
    Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urea kinetics with dialyzer reuse--a prospective study.
    Sridhar NR; Ferrand K; Reger D; Hayes P; Pinnavaia L; Butts D; Kohli R; Papandenatos G
    Am J Nephrol; 1999; 19(6):668-73. PubMed ID: 10592361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dialyzer reuse on dialysis delivery.
    Sherman RA; Cody RP; Rogers ME; Solanchick JC
    Am J Kidney Dis; 1994 Dec; 24(6):924-6. PubMed ID: 7985670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adequacy of fragmin as a single bolus dose with reused dialyzers.
    Kerr PG; Mattingly S; Lo A; Atkins RC
    Artif Organs; 1994 Jun; 18(6):416-9. PubMed ID: 8060249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended reuse of polysulfone hemodialysis membranes using citric acid and heat.
    Tonelli M; Dymond C; Gourishankar S; Jindal KK
    ASAIO J; 2004; 50(1):98-101. PubMed ID: 14763499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
    Leypoldt JK; Cheung AK; Deeter RB
    Am J Kidney Dis; 1998 Aug; 32(2):295-301. PubMed ID: 9708616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin modeling on delivered hemodialysis therapy.
    Wei SS; Ellis PW; Magnusson MO; Paganini EP
    Am J Kidney Dis; 1994 Mar; 23(3):389-93. PubMed ID: 8128940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of erythropoietin treatment on urea kinetic parameters in hemodialysis patients.
    van Geelen JA; Nubé MJ; Zuurbier PA
    Clin Nephrol; 1991 Apr; 35(4):165-70. PubMed ID: 1855319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of urea kinetic modeling for evaluating the efficacy of reusing capillary dialyzers].
    Drozdz M; Sułowicz W; Drozdz D; Kopeć J
    Przegl Lek; 1996; 53(5):406-11. PubMed ID: 8754402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzer reuse-Part I: Historical perspective.
    Twardowski ZJ
    Semin Dial; 2006; 19(1):41-53. PubMed ID: 16423181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.
    Canaud B; Polito-Bouloux C; Garred LJ; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Am J Kidney Dis; 1990 Feb; 15(2):169-75. PubMed ID: 2301388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialyzer reuse on survival of patients treated with hemodialysis.
    Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ
    JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Adequacy of Dialysis between Single-use and Reused Hemodialyzers in Patients on Maintenance Hemodialysis.
    Hamid A; Dhrolia MF; Imtiaz S; Qureshi R; Ahmad A
    J Coll Physicians Surg Pak; 2019 Aug; 29(8):720-723. PubMed ID: 31358090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis.
    Canaud B; Bouloux C; Rivory JP; Taib J; Garred LJ; Florence P; Mion C
    Blood Purif; 1990; 8(5):301-8. PubMed ID: 2091690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.